Results 101 to 110 of about 4,550 (156)

Improving the cytotoxicity of immunotoxins by reducing the affinity of the antibody in acidic pH. [PDF]

J Transl Med, 2023
Liu X, Tan Q, Wen J, Wang X, Yang G, Li Y, Lu M, Ye W, Si A, Ma S, Ding T, Sun L, Liu F, Zhang M, Jiang T, Gao W.   +15 more
europepmc   +1 more source

Design and Characterization of Ricin Based Immunotoxins Against EPHA2 Receptor for Breast Cancer Therapy: An In-Silico Study. [PDF]

Iran J Pharm Res
Faraz A, Amani J, Arbabian S, Zare Karizi S, Bikhof Torbati M.   +4 more
europepmc   +1 more source

GRP78 Nanobody-Directed Immunotoxin Activates Innate Immunity Through STING Pathway to Synergize Tumor Immunotherapy. [PDF]

Adv Sci (Weinh)
Wang H, Zhou R, Xu C, Dai L, Hou R, Zheng L, Fu C, Shi G, Wang J, Li Y, Cen J, Xu X, Yu L, Li Y, Wang J, Du Q, Li Z.   +16 more
europepmc   +1 more source

Critical appraisal of "A cross-sectional study on the effects of intravesical BCG on urinary microbiota in bladder cancer patients". [PDF]

Ann Med Surg (Lond)
Ali HS, Bilal E, Noor H, Khalid M, Ria SG.   +4 more
europepmc   +1 more source

Targeting of specific neuronal types in the non-human primate brain by using a murine CD25-specific recombinant immunotoxin. [PDF]

Sci Rep
Kobayashi T, Kato S, Kimura S, Sugawara M, Ihara K, Ozawa T, Inoue KI, Takada M, Onda M, Kobayashi K.   +9 more
europepmc   +1 more source

Immunotoxin‐Induced Apoptosis [PDF]

STEM CELLS, 2000
openaire   +2 more sources

Lethal toxin-equipped effector cells for the potential treatment of cancer. [PDF]

Proc Natl Acad Sci U S A
Pearlman AH, Mog BJ, Hwang MS, Rincon-Torroella J, DiNapoli SR, Paul S, Douglass J, Hsiue EH, Glavaris SA, Pardoll DM, Papadopoulos N, Kinzler KW, Bettegowda C, Zhou S, Vogelstein B, Konig MF.   +15 more
europepmc   +1 more source

Targeting the CD47-TSP1 Axis in Abdominal Aortic Aneurysm: A Novel Immunotherapeutic Approach. [PDF]

Int J Mol Sci
Stępień KL, Janas K, Rojek S.
europepmc   +1 more source

Immunotoxin-mediated depletion of Gag-specific CD8+ T cells undermines natural control of SIV. [PDF]

JCI Insight
Simpson J, Starke CE, Ortiz AM, Ransier A, Darko S, Llewellyn-Lacey S, Fennessey CM, Keele BF, Douek DC, Price DA, Brenchley JM.   +10 more
europepmc   +1 more source

Major Histocompatibility Complex Class I Matching is Necessary but not Sufficient for Tolerance Induction to Vascularized Composite Allografts After Donor Hematopoietic Cell Transplantation. [PDF]

Transplant Direct
Manell E, Gunes ME, Merl S, Patwardhan S, Chauhan I, Hong J, Chen B, Jordache P, Almesalmy A, Ekanayake-Alper D, Hajosi D, Husain S, Wuu CS, Wright M, Bogue J, Rohde C, Shanmugarajah K, Cetrulo CL, Sachs DH, Weiner J.   +19 more
europepmc   +1 more source